ADCY9 antibody (AA 137-186)
Quick Overview for ADCY9 antibody (AA 137-186) (ABIN1451832)
Target
See all ADCY9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 137-186
-
Purpose
- A Cyclase IX Antibody
-
Specificity
- A Cyclase IX Polyclonal Antibody detects endogenous levels of A Cyclase IX protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Purity
- > 95 %
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human ADCY9. AA range:137-186
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:10000.. IF 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C/1 year
-
Expiry Date
- 12 months
-
-
- ADCY9 (Adenylate Cyclase 9 (ADCY9))
-
Alternative Name
- ADCY9
-
Background
-
Synonyms: ADCY9, KIAA0520, Adenylate cyclase type 9, ATP pyrophosphate-lyase 9, Adenylate cyclase type IX, Adenylyl cyclase 9
Background: Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. It is regulated by a family of G protein-coupled receptors, protein kinases, and calcium. The type 9 adenylyl cyclase is a widely distributed adenylyl cyclase, and it is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, calcium, and somatostatin. [provided by RefSeq, Jul 2008],
Gene Name: ADCY9
Protein Name: Adenylate cyclase type 9
-
Molecular Weight
- 150 kDa
-
Gene ID
- 115
-
OMIM
- 603302
-
UniProt
- O60503
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Target
-